REFERENCES
1. Chai J, Jamal MM. Esophageal malignancy: a growing concern. World J Gastroenterol 2012;18:6521-6.
2. Lerut T. Carcinoma of the esophagus and gastro-esophageal junction. 2001.
3. Wu AW, Ji JF. Adenocarcinoma of esophagogastric junction requires a clearer definition. Transl Gastrointest Cancer 2013;2:5-9.
4. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457-9.
5. Wittekind Ch, Sobin LH, Gospodarowicz MK. TNM classification of malignant tumours. 7th ed. Blackwell Publishing Ltd; 2009.
6. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, et al. AJCC Cancer Staging Manual. 8th ed. Springer; 2017.
7. Kshivets O. Cardioesophageal cancer: best treatment strategies. Open Cardiovasc Thorac Surg J 2009;2:21-32.
8. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6.
9. Wu AW, Ji JF, Yang H, Li YN, Li SX, et al. Long-term outcome of a large series of gastric cancer patients in China,. Chinese J Cancer Res 2010;22:167-75.
10. Cellini F, Morganti AG, Di Matteo FM, Mattiucci GC, Valentini V. Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach. Radiat Oncol 2014;9:45.
11. Ekström AM, Signorello LB, Hansson LE, Bergström R, Lindgren A, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91:786-90.
12. Kauer WK, Peters JH, DeMeester TR, Feussner H, Ireland AP, et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997;122:874-81.
13. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269-74.
14. Miyashita T., Ohta T., Fujimura T., Ninomiya I., Fushida S., et al. Duodenal juice stimulates oesophageal stem cells to induce Barrett’s oesophagus and oesophageal adenocarcinoma in rats. Oncol Rep 2006:1469-75.
15. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-61.
16. Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008;57:173-80.
17. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, et al. Association of helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010;139:73-83.
18. Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 2013;23:3-9.
19. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010;102:1344-53.
20. Fukuzawa M, Gotoda T. History of endoscopic submucosal dissection and role for colorectal endoscopic submucosal dissection: a Japanese perspective. Gastrointest Interv 2012;1:30-5.
21. Hosokawa K, Yoshida S. Recent advances in endoscopic mucosal resection for early gastric cancer. Gan To Kagaku Ryoho 1998;25:476-83.
22. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:225-9.
23. Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc 1999:560-3.
24. Toyonaga T, Man-i M, East JE, Nishino E, Ono W, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc 2013:1000-8.
25. Nagami Y, Ominami M, Otani K, Hosomi S, Tanaka F, et al. Endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. Digestion 2018:38-44.
26. Park CH, Kim EH, Kim HY, Roh YH, Lee YC. Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis. Dig Liver Dis 2015;47:37-44.
27. Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD, et al. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer 2017;20:84-91.
28. Osumi H, Fujisaki J, Omae M, Shimizu T, Yoshio T, et al. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett’s esophageal adenocarcinoma following endoscopic submucosal dissection,. Gastric Cancer 2017;20:663-70.
29. Nagami Y, Machida H, Shiba M, Obayashi T, Ominami M, et al. Clinical efficacy of endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. Endosc Int Open 2014;2:E15-E20.
30. Tanimoto MA, Villalobos GT, Fujita R, Doherty PS, Saavedra JA, et al. Learning curve in a western training center of the circumferential en bloc esophageal endoscopic submucosal dissection in an in vivo animal model. Diagn Ther Endosc 2011;2011:847831.
31. Oda I, Odagaki T, Suzuki H, Nonaka S, Yoshinaga S. Learning curve for endoscopic submucosal dissection of early gastric cancer based on trainee experience. Dig Endosc 2012;24 Suppl 1:129-32.
32. Kato M, Gromski M, Jung Y, Chuttani R, Matthes K. The learning curve for endoscopic submucosal dissection in an established experimental setting. Surg Endosc 2013;27:154-61.
33. Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-9.
34. Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 2012;42:351-8.
35. Pedrazzani C, De Manzoni G, Marrelli D, Giacopuzzi S, Corso G, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 2007;134:378-85.
36. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the Esophago-Gastric Junction. Scand J Surg 2006;95:260-9.
37. Matsuda T, Takeuchi H, Tsuwano S, Nakamura R, Takahashi T, et al. Optimal surgical management for esophagogastric junction carcinoma. Gen Thorac Cardiovasc Surg 2014;62:560-6.
38. Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 2006;15:751-64.
39. von Rahden BH, Stein HJ, Siewert JR. Surgical management of esophagogastric junction tumors. World J Gastroenterol 2006;12:6608-13.
40. Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction. Ann Surg 2011;253:689-98.
41. Hulscher JB, van Sandick JW, de Boer A.G., Wijnhoven B.P., Tijssen J.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
42. Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7:644-51.
43. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Ann Surg 2007;246:992-1000. discussion 1000-1
44. Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 2015;102:341-8.
45. Chan DSY, Reid TD, Howell I, Lewis WG. Systematic review and meta-analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer,. Br J Surg 2013;100:456-64.
46. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012;379:1887-92.
47. Biere SSAY, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir 2009:121-33.
48. Verhage RJJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 2009;64:135-46.
49. Santillan AA, Farma JM, Meredith KL, Shah NR, Kelley ST. Minimally invasive surgery for esophageal cancer. J Natl Compr Canc Netw 2008:879-84.
50. Cunningham D, Allum WH, Stenning SP, Thompson GN, Van de Velde CJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
51. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
52. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-84.
53. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
54. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012;379:315-21.
55. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-20.
56. Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015;16:1090-8.
57. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-6.
